GRAPCHINA 2025: Breakthrough Achievements and Rapid Industrial Expansion Signal a New Era for Graphene

Event: 2025 (12th) China International Graphene Innovation Conference
Date: November 14–16, 2025
Location: Yueqing, Wenzhou, Zhejiang Province (now officially the permanent host city)
Theme: “Industrial Renewal, Creating a Graphene Future”
Hosted by: CHINT Group & China Innovation Alliance of the Graphene Industry (CGIA)

1. Key Highlights & Industry Trends

Eight Core Breakthroughs Released — Applications Become the Focus

At the opening ceremony, the conference unveiled eight major graphene breakthroughs, marking a strong shift from laboratory research to real industrial applications. Highlights include:

Advanced Manufacturing

• Monoene fiber, graphene-based carbon fiber, and other next-generation structural materials.

• New material platforms supporting high-performance composites and lightweight structures.

Electronics & Semiconductors

• 8-inch graphene wafer mass-production technology—a major step toward the carbon-based chip era.

• Commercialization of high-performance graphene heat-dissipation solutions for advanced chips.

Energy & Healthcare

• Instant-heating tube technology providing new solutions for China’s carbon-neutrality goals.

• World’s first human clinical trial completed for a graphene-based brain–computer interface.

Industrial Chain Breakthrough

CHINT Group achieved pilot-scale production for room-temperature ultra-conductive graphene–copper composite materials, enabling large-scale use in energy and power grid applications.

2. Deep Industrial Integration & Ecosystem Building

GRAPCHINA 2025 is no longer just an academic conference—it has become a multi-industry integration platform linking technology, capital, and applications.

Participation from Global Industry Leaders

Fortune 500 companies—including State Grid, BYD, CRRC, and Midea—joined thematic forums on:

• Electrical systems

• Energy & storage

• Transportation & vehicles

• Consumer electronics

This strengthened collaboration between graphene suppliers and downstream application industries.

“Technology + Industry + Capital” Development Model

Six strategic cooperation agreements were signed, covering:

• Permanent GRAPCHINA venue in Yueqing

• Graphene industrialization and application bases

• New capital–technology joint development programs

The aim is to accelerate full-chain deployment from R&D to mass production.

China’s Global Leadership

• 80% of global graphene patent applications come from China.

• As of 2024, China accounts for 53% of global graphene production capacity—the world’s largest manufacturing base.

• China represents over 60% of the global market share.

Market Outlook

The global graphene application market is expected to exceed ¥300 billion (USD 40+ billion) by 2030, with a CAGR above 30%. Experts believe the next decade will be the “golden era of graphene commercialization.”

3. Graphene in the Healthcare Industry — Rapid Rise Toward Large-Scale Commercialization

The graphene healthcare sector is undergoing explosive growth, driven by its unique properties:

• Ultra-high thermal conductivity

• Far-infrared emission

• Biocompatibility

• Precision sensing capability

Technology Breakthroughs & Safety Validation

Medical-Grade Purification

• Shandong Xiyou Technology reduced graphene metallic impurities to 0.1 ppm (far below the international benchmark of 1 ppm).

• Fully passed biocompatibility testing for medical-grade applications.

Multi-Functional Applications

• Flexible graphene sensors detecting biopotential signals as low as 0.1 mV.

• Far-infrared graphene heaters achieving ±0.5°C precision control.

• Graphene drug-delivery platforms enabling targeted therapy.

Safety Verification

A UK clinical study confirmed that certain medical-grade graphene samples showed no short-term pulmonary or cardiovascular risks during controlled inhalation trials.

Growing Use Cases in Healthcare

Rehabilitation & Pain Relief

AI-controlled graphene far-infrared therapy devices demonstrated improved outcomes for:

• Lumbar disc herniation

• Muscle strain

• Chronic inflammation recovery

Non-Invasive Therapies

A graphene “spectral light therapy chamber” developed by EwaTech received Class II medical device approval, effective for 23 types of clinical indications.

Cancer Adjunct Therapies

Graphene thermal therapy induces targeted tumor cell apoptosis and enhances chemotherapy sensitivity.

Market and Policy Acceleration

• China’s graphene medical market reached ¥32 billion in 2024.

• Over 25,000 graphene medical patents filed worldwide.

• Shenzhen established the Graphene Life & Health Alliance and released new industry standards.

• Guangxi launched a pilot program for medical-device regulatory innovation.

4. Outlook: Graphene Enters the Fast Lane

The November 2025 GRAPCHINA conference sends a clear signal:

Graphene is transitioning from “samples” to “products,” and from concept validation to mass commercial deployment.

With stronger links between universities, institutes, manufacturers, and end-use industries—and with China leading global production and application—graphene healthcare and advanced materials industries are expected to enter a period of rapid expansion over the next decade.